NASDAQ:BCRX
BioCryst Pharmaceuticals Stock News
$6.47
+0.110 (+1.73%)
At Close: May 16, 2024
Will BioCryst Pharmaceuticals (BCRX) Report Negative Earnings Next Week? What You Should Know
04:34pm, Wednesday, 29'th Apr 2020
BioCryst (BCRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will BioCryst Pharmaceuticals (BCRX) Report Negative Earnings Next Week? What You Should Know
04:34pm, Wednesday, 29'th Apr 2020
BioCryst (BCRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Positive remdesivir news 'bodes well' for BioCryst, says JMP Securities BCRX;GILD
03:37pm, Wednesday, 29'th Apr 2020
Positive remdesivir news 'bodes well' for BioCryst, says JMP Securities JMP Securities BCRX GILD
Gilead’s Coronavirus Drug Success Spurs Biotech Stocks to Outperform
01:23pm, Wednesday, 29'th Apr 2020GOOGL, CHK among premarket gainers
01:21pm, Wednesday, 29'th Apr 2020
Spark Networks SE (NYSEMKT:LOV) +38% on 2H results.Chimerix (NASDAQ:CMRX) +29% on launch of DSTAT study in COVID-19.resTORbio (NASDAQ:TORC) +24% on merger with Adicet BioR. R. Donnelley & Sons (NY
3 Reasons Why Investing in Coronavirus Vaccine Stocks Is a Sucker’s Game
09:30pm, Tuesday, 28'th Apr 2020
The race to develop a coronavirus vaccine is on. Moderna and Inovio stocks have consequently surged. Will investing in these stocks pay off?
Triangle pharma files $500 million shelf offering as it explores potential coronavirus treatment
06:54pm, Tuesday, 28'th Apr 2020
Jon Stonehouse, CEO of BioCryst Pharmaceuticals.
Cramer Shares His Thoughts On Slack, Archer Daniels Midland And More
01:17pm, Tuesday, 28'th Apr 2020
On CNBC's "Mad Money Lightning Round," Jim Cramer said that Archer Daniels Midland Co (NYSE: ADM) is a chronic underperformer. Those who like it for yield, should...
BioCryst Pharmaceuticals (BCRX) Stock Sinks As Market Gains: What You Should Know
09:50pm, Monday, 27'th Apr 2020
BioCryst Pharmaceuticals (BCRX) closed at $3.55 in the latest trading session, marking a -0.28% move from the prior day.
BioCryst Pharmaceuticals (BCRX) Stock Sinks As Market Gains: What You Should Know
09:50pm, Monday, 27'th Apr 2020
BioCryst Pharmaceuticals (BCRX) closed at $3.55 in the latest trading session, marking a -0.28% move from the prior day.
Is BioCryst Pharmaceuticals (BCRX) Outperforming Other Medical Stocks This Year?
03:30pm, Monday, 27'th Apr 2020
Is (BCRX) Outperforming Other Medical Stocks This Year?
Is BioCryst Pharmaceuticals (BCRX) Outperforming Other Medical Stocks This Year?
03:30pm, Monday, 27'th Apr 2020
Is (BCRX) Outperforming Other Medical Stocks This Year?
3 Biotech Stocks Under $4 With Big Upside Potential
11:51am, Sunday, 26'th Apr 2020
At the very moment it looked like the market was down for the count, stocks bounced back. After being dealt hefty blows earlier in the week due to the record-breaking drop in oil prices, all three of
3 Biotech Stocks Under $4 With Big Upside Potential
11:48am, Sunday, 26'th Apr 2020
At the very moment it looked like the market was down for the count, stocks bounced back. After being dealt hefty blows earlier in the week due to
BioCryst Pharmaceuticals (NASDAQ:BCRX) vs. Acorda Therapeutics (NASDAQ:ACOR) Critical Survey
05:42am, Sunday, 26'th Apr 2020
BioCryst Pharmaceuticals (NASDAQ:BCRX) and Acorda Therapeutics (NASDAQ:ACOR) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the st
